article thumbnail

ACA Council on Chiropractic Pediatrics launches 2025-2026 hybrid program cohort

Chiropractic Economics

The American Chiropractic Association (ACA) Council on Chiropractic Pediatrics has launched its 2025-2026 hybrid program, a 300-hour course of study that prepares doctors of chiropractic for the pediatrics diplomate certification exam. To learn more, visit acatoday.org.

article thumbnail

Laser focus boosting athletic performance with low-level laser therapy

Chiropractic Economics

The benefits of low-level laser therapy for peak athletic performance: An example At APEX Brain Centers, we harness the power of all three light sources and are realizing the treatment times for both injury and peak athletic performance being dramatically reduced. We can’t wait to see what he does in 2026. as quickly as possible.

Ligaments 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Osteochondritis Dissecans of the Knee

Orthopedic Principles

Courtesy: Prof Michael Hantes, ESSKA 1st Vice President Ivory Orange Modern Meet Our Team Instagram Post – 1 Lecture Topic: Osteochondritis Dissecans of the Knee Aim: Define the treatment algorithm for this disease. Treatment depends on: Age, lesion size, symptoms, and patient expectations. Avoidance of high-impact sports.

X-ray 52
article thumbnail

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

OrthoSpineNews

OrthoPreserve’s implant addresses a significant treatment gap that exists due to the poor outcomes of the standard of care for meniscus tears, a partial meniscectomy, which removes the damaged tissue. OrthoPreserve’s proprietary technology has the potential to disrupt the standard of care and displace more invasive treatments.

article thumbnail

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

OrthoSpineNews

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded with initial interim results expected in Q2 2026 BROOMFIELD, Colo.,

Spine 52
article thumbnail

restor3d Secures $38 Million in Growth Capital to Drive Expansion and Innovation in Personalized Orthopedic Solutions

OrthoSpineNews

The investments will fuel the companys continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment.